RLAY
Relay Therapeutics·NASDAQ
--
--(--)
--
--(--)
RLAY fundamentals
Relay Therapeutics (RLAY) released its earnings on Feb 26, 2026: revenue was 7.00M (YoY --), beat estimates; EPS was -0.32 (YoY +28.89%), beat estimates.
Revenue / YoY
7.00M
--
EPS / YoY
-0.32
+28.89%
Report date
Feb 26, 2026
Earnings
EPS
Revenue
Revenue & Expenses
RLAY has released its 2025 Q4 earnings report, with revenue of 7.00M, reflecting a YoY change of NaN%, and net profit of -54.89M, showing a YoY change of 27.78%. The Sankey diagram below clearly presents RLAY's revenue sources and cost distribution.
Key Indicators
Relay Therapeutics (RLAY) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
Relay Therapeutics (RLAY)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
Relay Therapeutics (RLAY)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
Relay Therapeutics (RLAY)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does Relay Therapeutics (RLAY) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track Relay Therapeutics (RLAY) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What were the key takeaways from Relay Therapeutics’s earnings call?What is Relay Therapeutics's gross profit margin?What is the market's earnings forecast for Relay Therapeutics next quarter?What factors drove the changes in Relay Therapeutics's revenue and profit?What guidance did Relay Therapeutics's management provide for the next earnings period?What is Relay Therapeutics's latest dividend and current dividend yield?What were the key takeaways from Relay Therapeutics's earnings call?Did Relay Therapeutics beat or miss consensus estimates last quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
